Interleukin-4 regulates macrophage polarization and osteogenic differentiation of bone marrow mesenchymal stem cells

doi:10.12307/2024.189

Abstract

Abstract: BACKGROUND: Interleukin-4 can promote the osteogenic effect of bone substitute materials, but its molecular mechanism is not yet clear. Further elucidating the mechanism of interleukin-4 promoting osteogenic effect can help find safe, economical, and effective methods for the regeneration treatment of alveolar bone defects in patients.
OBJECTIVE: To explore the effect of interleukin-4 intervention on polarization transformation of macrophages and osteogenic differentiation of bone marrow mesenchymal stem cells and its possible mechanism.
METHODS: RAW264.7 cells in the M1 group were induced with interferon gamma + lipopolysaccharide for 24 hours. RAW264.7 cells in the interleukin-4+M1 group were induced with interferon gamma + lipopolysaccharide for 24 hours and then interleukin-4 was added for 24 hours. RAW264.7 cells in the interleukin-4+AG+M1 group were induced with interferon gamma + lipopolysaccharide for 24 hours, and then interleukin-4 and AG-490, a JAK/STAT pathway inhibitor, were added for 24 hours. After intervention, immunofluorescence staining was used to analyze the expression of inducible nitric oxide synthase and CD206, the phenotypic marker protein of macrophages. ELISA kit was used to detect the expression of interleukin-10 and tumor necrosis factor-α in the supernatant of cell culture. The gene expressions of nodular receptor protein-3 (NLRP3), interleukin-1β, and caspase-1 were detected by RT-qPCR. The expression levels of tyrosine protein kinase 1 (JAK1)/ phosphorylated tyrosine protein kinase 1 (p-JAK1), signal transduction and transcription activator 6 (STAT6)/phosphorylated signal transduction and transcription activator 6 (p-STAT6), NLRP3, pro-interleukin-1β and pro-caspase-1 were detected by western blot assay. Then, RAW264.7 cells in the above four groups were indirectly co-cultured with bone marrow mesenchymal stem cells by transwell for 24 hours, followed by alkaline phosphatase staining and alizarin red staining. The mRNA expressions of alkaline phosphatase, collagen type I, and osteocalcin were detected by RT-qPCR.
RESULTS AND CONCLUSION: (1) Immunofluorescence and ELISA results showed that interleukin-4 intervention could promote the expression of CD206 and interleukin-10 in M2 macrophages, and inhibit the secretion of inducible nitric oxide synthase and tumor necrosis factor-α. (2) RT-qPCR results showed that interleukin-4 could suppress the expression of NLRP3, interleukin-1β, and caspase-1 mRNAs. (3) Western blot assay showed that interleukin-4 could promote the expression of JAK1/p-JAK1, STAT6/p-STAT6 and NLRP3 proteins. (4) The alkaline phosphatase staining and alizarin red staining of bone marrow mesenchymal stem cells co-cultured with the interleukin-4+M1 group were significantly enhanced, and the mRNA expressions of alkaline phosphatase, collagen type I, and osteocalcin were significantly increased. It is concluded that interleukin-4 may inhibit the activation of NLRP3 by up-regulating JAK1/STAT6 pathway, thus promoting the transformation of macrophages from M1 polarization to M2 polarization, and finally enhancing the osteogenic differentiation ability of bone marrow mesenchymal stem cells.

Key words: macrophage, interleukin-4, NLRP3 inflammatory, JAK/STAT signaling pathway, osteogenic differentiation

CLC Number:

Zhang Jie, Xiao Tianjiao, Li Li, Kang Jiabing, Zhan Jifan, Wei Yan, Tian Ai. Interleukin-4 regulates macrophage polarization and osteogenic differentiation of bone marrow mesenchymal stem cells[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(25): 3960-3966.

Figures/Tables 5

References

[1] AMENGUAL-PEÑAFIEL L, BRAÑES-AROCA M, MARCHESANI-CARRASCO F, et al. Coupling between Osseointegration and Mechanotransduction to Maintain Foreign Body Equilibrium in the Long-Term: A Comprehensive Overview. J Clin Med. 2019;8(2):139.
[2] ARRON JR, CHOI Y. Bone versus immune system. Nature. 2000;408(6812): 535-536.
[3] SALEH LS, BRYANT SJ. The Host Response in Tissue Engineering: Crosstalk Between Immune cells and Cell-laden Scaffolds. Curr Opin Biomed Eng. 2018;6:58-65.
[4] PAJARINEN J, LIN T, GIBON E, et al. Mesenchymal stem cell-macrophage crosstalk and bone healing. Biomaterials. 2019;196:80-89.
[5] MICHALSKI MN, MCCAULEY LK. Macrophages and skeletal health. Pharmacol Ther. 2017;174:43-54.
[6] ZHENG ZW, CHEN YH, WU DY, et al. Development of an Accurate and Proactive Immunomodulatory Strategy to Improve Bone Substitute Material-Mediated Osteogenesis and Angiogenesis. Theranostics. 2018;8(19):5482-5500.
[7] JIN SS, HE DQ, LUO D, et al. A Biomimetic Hierarchical Nanointerface Orchestrates Macrophage Polarization and Mesenchymal Stem Cell Recruitment To Promote Endogenous Bone Regeneration. ACS Nano. 2019;13(6):6581-6595.
[8] ZHANG J, SHI H, ZHANG N, et al. Interleukin-4-loaded hydrogel scaffold regulates macrophages polarization to promote bone mesenchymal stem cells osteogenic differentiation via TGF-β1/Smad pathway for repair of bone defect. Cell Prolif. 2020;53(10):e12907.
[9] YU Y, CUI H, ZHANG C, et al. Human nail bed extracellular matrix facilitates bone regeneration via macrophage polarization mediated by the JAK2/STAT3 pathway. J Mater Chem B. 2020;8(18):4067-4079.
[10] LIU Y, GAO X, MIAO Y, et al. NLRP3 regulates macrophage M2 polarization through up-regulation of IL-4 in asthma. Biochem J. 2018;475(12):1995-2008.
[11] SONG N, LIU ZS, XUE W, et al. NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation. Mol Cell. 2017;68(1):185-197.
[12] FURUYA MY, ASANO T, SUMICHIKA Y, et al. Tofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils. Arthritis Res Ther. 2018;20(1):196.
[13] LI D, LI X, ZHANG J, et al. The immunomodulatory effect of IL-4 accelerates bone substitute material-mediated osteogenesis in aged rats via NLRP3 inflammasome inhibition. Front Immunol. 2023;14: 1121549.
[14] LASSUS J, SALO J, JIRANEK WA, et al. Macrophage activation results in bone resorption. Clin Orthop Relat Res. 1998;(352):7-15.
[15] WALKER DG, LUE LF. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther. 2015;7(1):56.
[16] PEREGO C, FUMAGALLI S, DE SIMONI MG. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation. 2011;8:174.
[17] FUMAGALLI S, PEREGO C, ORTOLANO F, et al. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia. 2013;61(6):827-842.
[18] MARTINEZ FO, GORDON S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
[19] WANG N, GAO J, JIA M, et al. Exendin-4 Induces Bone Marrow Stromal Cells Migration Through Bone Marrow-Derived Macrophages Polarization via PKA-STAT3 Signaling Pathway. Cell Physiol Biochem. 2017;44(5):1696-1714.
[20] KEEGAN AD, NELMS K, WANG LM, et al. Interleukin 4 receptor: signaling mechanisms. Immunol Today. 1994;15(9):423-432.
[21] KOH YC, YANG G, LAI CS, et al. Chemopreventive Effects of Phytochemicals and Medicines on M1/M2 Polarized Macrophage Role in Inflammation-Related Diseases. Int J Mol Sci. 2018;19(8):2208.
[22] XUAN YT, GUO Y, HAN H, et al. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A. 2001; 98(16):9050-9055.
[23] XIONG H, ZHANG ZG, TIAN XQ, et al. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia. 2008;10(3):287-297.
[24] SHARIF H, WANG L, WANG WL, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019; 570(7761):338-343.
[25] JIANG N, AN J, YANG K, et al. NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis? Front Endocrinol (Lausanne). 2021;12:752546.
[26] NETEA MG, NOLD-PETRY CA, NOLD MF, et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood. 2009;113(10):2324-2335.
[27] KONG X, LIU Y, YE R, et al. GSK3β is a checkpoint for TNF-α-mediated impaired osteogenic differentiation of mesenchymal stem cells in inflammatory microenvironments. Biochim Biophys Acta. 2013;1830(11):5119-5129.
[28] LOI F, CÓRDOVA LA, PAJARINEN J, et al. Inflammation, fracture and bone repair. Bone. 2016;86:119-130.
[29] ZHANG Y, BÖSE T, UNGER RE, et al. Macrophage type modulates osteogenic differentiation of adipose tissue MSCs. Cell Tissue Res. 2017;369(2):273-286.
[30] LOI F, CÓRDOVA LA, ZHANG R, et al. The effects of immunomodulation by macrophage subsets on osteogenesis in vitro. Stem Cell Res Ther. 2016;7:15.
[31] GENG Y, ZHANG L, FU B, et al. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Stem Cell Res Ther. 2014;5(3):80.
[32] LUZ-CRAWFORD P, JORGENSEN C, DJOUAD F. Mesenchymal Stem Cells Direct the Immunological Fate of Macrophages. Results Probl Cell Differ. 2017;62:61-72.